Dr. Shainker is the co-founder and director of the New England Center for Placental Disorders, an international referral center housed at Beth Israel Deaconess Medical Center for patients with placenta accreta spectrum and other complex placental disorders.
Publications
Recognizing the Work of Accretologists Worldwide. View Abstract
Reference Range Determination for the sFlt-1/PlGF Ratio in a Diverse Cohort of Pregnant Women in the United States. View Abstract
Placenta Accreta Spectrum, Present and Future: The Eunice Kennedy Shriver National Institute of Child Health and Human Development Workshop Summary. View Abstract
Amnioreduction safety in singleton pregnancies; systematic review and meta-analysis. View Abstract
Prenatal Aspiration of Fetal Ovarian Cysts: When to Intervene? A Case Report and Review of the Literature. View Abstract
Outcomes of Image-Guided Percutaneous Drainage versus Other Management Strategies for Infected Post-Cesarean Section Bladder Flap Hematoma. View Abstract
Evidence-based surgery for cesarean hysterectomy secondary to placenta accreta spectrum: A systematic review. View Abstract
Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus. View Abstract
Diagnostic fetoscopy: important resource for prenatal assessment. View Abstract
Risk Profiling In Vitro Fertilization Pregnancies that Develop Placenta Accreta Spectrum. View Abstract
Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum care. View Abstract
Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis. View Abstract
Imaging the Uterus in Placenta Accreta Spectrum Disorder. View Abstract
General Management Considerations for Placenta Accreta Spectrum. View Abstract
Knowledge Gaps in Placenta Accreta Spectrum. View Abstract
Surgical Techniques for the Management of Placenta Accreta Spectrum. View Abstract
Basal Plate Myofibers and the Risk of Placenta Accreta Spectrum in the Subsequent Pregnancy: A Large Single-Center Cohort. View Abstract
Modified Delphi study of ultrasound signs associated with placenta accreta spectrum. View Abstract
Physiology of the Critically Ill Pregnant Patient with COVID-19. View Abstract
Emergency department burden of hyperemesis gravidarum in the United States from 2006 to 2014. View Abstract
Primum, non nocere: Whole blood, prehospital transfusion and anti-D hemolytic disease of the fetus and newborn. View Abstract
The Association between Placenta Accreta Spectrum Severity and Incidence of Small for Gestational Age Neonates. View Abstract
Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis. View Abstract
Timing of delivery for placenta accreta spectrum: the Pan-American Society for the Placenta Accreta Spectrum experience. View Abstract
Patient Perception of Care, Outcomes, and Consequences from Placenta Accreta Spectrum: A Survey-Based Study. View Abstract
Timing of birth and adverse pregnancy outcomes in cases of prenatally diagnosed vasa previa: a systematic review and meta-analysis. View Abstract
The Society for Pediatric Pathology Task Force grading system for placenta accreta spectrum and its correlation with clinical outcomes. View Abstract
Conservative management of placenta accreta spectrum: is it time? View Abstract
COVID-19 in the Critically Ill Pregnant Patient. View Abstract
Geographic variation in management of patients with placenta accreta spectrum: An international survey of experts (GPASS). View Abstract
Quantitative T1 and T2 mapping by magnetic resonance fingerprinting (MRF) of the placenta before and after maternal hyperoxia. View Abstract
Correction to: Rapid Cycle Implementation and Retrospective Evaluation of a SARS-CoV-2 Checklist in Labor and Delivery. View Abstract
Rapid Cycle Implementation and Retrospective Evaluation of a SARS-CoV-2 Checklist in Labor and Delivery. View Abstract
One step closer to reducing PAS morbidity. View Abstract
Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. View Abstract
Pregnancy-associated arterial dissections: a nationwide cohort study. View Abstract
Adaptation of an obstetric anesthesia service for the SARS-CoV-2 pandemic: description of checklists, workflows, and development tools. View Abstract
Adaptation of an Obstetric Anesthesia Service for the Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Description of Checklists, Workflows, and Development Tools. View Abstract
Keeping Pregnant Patients Safe During COVID-19 Pandemic. View Abstract
Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients. View Abstract
A multidisciplinary telemedicine model for management of coronavirus disease 2019 (COVID-19) in obstetrical patients. View Abstract
A mouse model of placenta accreta spectrum. View Abstract
Placenta Accreta Spectrum: In Vitro Fertilization and Non-In Vitro Fertilization and Placenta Accreta Spectrum in a Massachusetts Cohort. View Abstract
Maternal mortality, abortion access, and optimizing care in an increasingly restrictive United States: A review of the current climate. View Abstract
Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. View Abstract
Placenta accreta spectrum: biomarker discovery using plasma proteomics. View Abstract
Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders. View Abstract
Characteristics and outcomes of placenta accreta spectrum in twins versus singletons: a study from the Pan American Society for Placenta Accreta Spectrum (PAS2). View Abstract
Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa. View Abstract